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Largemammals,includingcanidsandfelids,areaﬀectedbyspontaneouslyoccurringhereditaryretinaldiseaseswithsimilaritiesto
thoseofhumans.Thelargemammalmodelsmaybeusedforthoroughclinicalcharacterizationofdiseaseprocesses,understanding
the eﬀects of speciﬁc mutations, elucidation of disease mechanisms, and for development of therapeutic intervention. Two well-
characterized feline models are addressed in this paper. The ﬁrst model is the autosomal recessive, slowly progressive, late-onset,
rod-conedegenerativediseasecausedbyamutationintheCEP290gene.Thesecondmodeladdressedinthispaperistheautosomal
dominant early onset rod cone dysplasia, putatively caused by the mutation found in the CRX gene. Therapeutic trials have been
performed mainly in the former type including stem cell therapy, retinal transplantation, and development of ocular prosthetics.
Domestic cats, having large human-like eyes with comparable spontaneous retinal diseases, are also considered useful for gene
replacement therapy, thus functioning as eﬀective model systems for further research.
1.Introduction
The value of appropriate animal models to advance our
understanding and treatment of human retinal disease pro-
cesses that cause severe visual impairment or blindness
cannot be overemphasized. Animal models have led to the
identiﬁcation of disease genes, and elucidation of the molec-
ular genetic and cellular mechanisms underlying retinal
pathology. Moreover, they provide the basis for testing the
eﬃcacy of therapeutic approaches, including the use of
drugs and gene replacement [1], novel genetic approaches
(siRNA) [2], stem cell therapy [3], surgical intervention,
such as retinal transplantation [4], and the use of ocular
or retinal prosthetics [5]. Additionally, animal models can
lead to the identiﬁcation of novel genes underlying human
retinal pathology. Though 157 genes have been identiﬁed as
causative of nonsyndromic human retinitis pigmentosa (RP;
http://www.sph.uth.tmc.edu/retnet/home.htm),over50%of
the genetic causality of RP still remains uncharacterized [6].
Though the mouse has been the classic animal model of
retinal disease, the advent of comprehensive genetic maps of
many mammals has led to the identiﬁcation of a number
of non-rodent animal models of human hereditary retinal
disease. Many large animal models oﬀer a complement
to existing rodent models. The size of the rodent eye is
restrictive for visualization using regular clinical ophthalmic
instrumentation and also in conjunction with therapeutic
intervention. Even for detailed morphological studies the
small size of the mouse eye may be a problem. As a case in
point Pazour et al. previously reported that in their research2 Journal of Ophthalmology
examining the traﬃcking of ciliary protein in photoreceptor
cells, the physical limitations of the mouse retina led them to
resort to the use of a bovid eye [7].
2. Dogs and CatsasLargeAnimalModels of
SpontaneousRetinalDisease
Dog and cat populations oﬀer a wealth of potential as large
animal models of human retinal disease. Small eﬀective
populationsizes,theuseofpopularsiresandinbreedinghave
contributed to the “load” of inherited diseases, especially
in dog breeds [8]. Hereditary and primary photoreceptor
diseases, or progressive retinal atrophies (PRA) have been
described in more than 100 dog breeds [9], many of which
are likely to be caused by the same mutation which is
observed across related breeds. This phenomenon has been
observed in a number of gene-deﬁning phenotypes in the
dog [10–12]. Thirteen genes have been mapped and charac-
terized as causative of canine PRA, including ADAM9 [13],
CCDC66 [14],CNGB3[15],PDE6α[16],PDE6β [17],PR CD
[18], RD3 [19], RHO [20], RPE65 [21], RPHP4 [22], RPGR
[23], RPGRIP1 [24], and VMD2 [25].
Cats have been considered to be aﬀected less frequently
by hereditary disease. However, the informative website
Online Mendelian Inheritance in Animals (http://omia.
angis.org.au/) catalogues 288 distinctive pathologies with an
inherited component in the cat, with cited references. Only
in recent years have speciﬁc mutations been elucidated for
hereditary retinal diseases in cats [26, 27], clinically similar
to the PRA complex in dogs [28]. Domestic dogs and cats
of today experience a level of medical surveillance second
only to human kind, thus increasing the likelihood, that
individuals with rare or unique mutations are identiﬁed.
3. Sequencingof the Cat Genome
Report of two partial sequences (1.9X, 3X) of the cat genome
[29, 30] has been invaluable in the initial mapping and
characterization of feline hereditary diseases [26, 27, 31]. A
full genome sequence (14X) of the cat has currently been
completed (Wes Warren, Washington University, personal
communication). The identiﬁcation of single-nucleotide
polymorphisms (SNP) in cat breeds, an integral part of the
14X full genome sequence project and the 3X sequencing of
the cat genome [30] is currently being utilized in develop-
ment of a domestic cat SNP chip. With the availability of
these genomic resources, the mapping and characterization
of feline monogenic disorders will largely be dependent on
obtaining an appropriate sample set. Genome-wide associ-
ation (GWA) studies in dog breeds are proving extremely
successfulinidentifyinggenesassociatedwithbreed-deﬁning
phenotypes and monogenic disorders [13, 32, 33]. Often
this is accomplished with surprisingly small sample sizes.
The mapping of the canine cone-rod dystrophy 3 gene
(ADAMS9) in the Glen of Imaal Terrier breed was recently
accomplished with as few as 22 unaﬀected and 19 aﬀected
individuals [13] while Awano et al. reported identiﬁcation
of the gene causative of canine degenerative myelopathy
(SOD1) in the Pembroke Welsh corgi with 38 aﬀected and 17
controlindividuals.Extendedlinkagedisequilibrium(LD)in
dog breeds [19, 34, 35] contributes to the success of GWA
mapping in dogs and is an important factor underlying
successful mapping with small sample sizes in the dog.
Preliminary studies suggest that extended blocks of LD are
also observed in cat breeds, though the length of LD appears
to be abbreviated to that which is observed in dog breeds
[29].
4. The AbyssinianRetinal Degeneration
CatModel(rdAc)
The female Abyssinian cat (Cinnamon), subject of the feline
whole genome sequencing eﬀorts, is a member of a pedigree
developed for genetic mapping of the gene defect for the
rdAc (retinal degeneration in Abyssinian cats) model, ﬁrst
described in 1982 [36]. The autosomal recessive (AR) trait,
rdAc, hasbecomean important model ofhuman RP[37,38].
At birth, aﬀected cats have normal vision, but, by 1.5–2 years
of age they develop early changes that can be observed by
ophthalmoscopy [39] (Figures 1(a)–1(c)). By 7 months of
age, aﬀected cats demonstrate signiﬁcantly reduced retinal
function by electroretinography (ERG; Figure 1(d)). ERG
a-wave amplitudes are then reduced more than 50% as
compared to normal individuals, with a parallel reduction
in retinal oxygen tension [40]. Rod photoreceptor outer
segments exhibit the ﬁrst morphological changes in indi-
viduals 5–8 months of age, observed as a disorganization
and disruption of rod outer segment lamellar discs and the
appearance of vacuoles near the connecting cilium [41].
Progression of the disease results in further degeneration
of the rods (Figures 2(a) and 2(b)), followed also by
disruption of the cone photoreceptors. By 3–5 years of age,
the clinical end stage of the disease has been reached with
generalized photoreceptor degeneration, and subsequently
retinal atrophy leads to blindness [42].
The molecular genetic basis of rdAc was recently estab-
lished in the CEP290 gene. A single-nucleotide polymor-
phism in an intron of the felid CEP290 gene generates
a novel strong canonical splice-donor site resulting in a
4-bp insertion, a frame shift, and the introduction of a
premature stop codon (Figures 3(a) and 3(b)). The putative
truncated CEP290 peptide would lack the more 3  KIDV
and VI domains. The protein is an important component of
the intraﬂagellar transport (IFT) system whereby specialized
proteins critical for phototransduction are transferred from
their site of synthesis in the inner segment of photoreceptors
through the connecting cilium to the outer segment [7].
As the rod photoreceptor discs are in a constant state
of regeneration, a fully functional IFT system is critical
for the maintenance of the photoreceptors [7]. In the
rd16 mouse model, the phototransduction proteins opsin
and rhodopsin are found concentrated in the inner segment,
which led Chang et al. [44] to propose a ciliary traﬃcking
role for the CEP290 protein. Mutations in CEP290 have been
reported in RP, Leber’s congenital amaurosis (LCA), as well
as the syndromic retinopathies, Joubert, Meckel-Gruber, and
Bardet-Biedl [45–48].Journal of Ophthalmology 3
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Figure 1: Fundus appearance and electroretinograms (ERGs) of rdAc individuals with the CEP290 mutation. Fundus photographs demon-
strate (a) a 1-year-old unaﬀected Abyssinian cat (wildtype, WT), (b) a 2-year-old aﬀected Abyssinian cat with an early disease stage (S2)
[39], and (c) a 6-year-old Abyssinian with an advanced disease stage (S4) [39]. Arrows in (b) and (c) indicate retinal vasculature that is
attenuated, more so in the advanced stage (c) than in early stage of disease (b). For the same three cats, the waveforms of the dark-adapted
full-ﬁeld ﬂash ERG recordings are shown, using 4cd.s/m2 of white light stimulation for each of the recordings. Amplitude and implicit time
calibrations are indicated in the ﬁgure, vertically and horizontally, respectively. Reproduced with permission from [43].
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Figure 2: Electron micrographs of outer retina showing photoreceptor outer and inner segments of normal (a) Abyssinian cat and young
aﬀected (b) rdAc cat. Note abnormalities at the base of the rod outer segments near the connecting cilium in (b); membranes are not formed
as in the normal (a), instead there is vacuolization and degeneration (arrows) of membranes in the aﬀected retina. Am: apical microvilli
of the retinal pigment epithelium, ros: rod outer segments, ris: rod inner segments, cos: cone outer segments, cis: cone inner segments, cc:
connecting cilium of the photoreceptor. Original magniﬁcation: ×19152. Reproduced with permission from [27].4 Journal of Ophthalmology
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Figure 3: (a) Electropherograms of genomic DNA of CEP290
sequenced in unaﬀected and rdAc aﬀected individuals of exon
50/intron 50 junction. Arrow indicates position of SNP in intron
50, which uncovers a canonical GT splice donor site, resulting in
alternative splicing in aﬀected individuals. Exon 50 (red letters)
and intron 50 (blue letters) nucleotides were identiﬁed by cDNA
sequence analysis. GenBank Accession No. for feline CEP290:
EF028068. (b) Electropherograms of cDNA for CEP290 3  region
of exon 50 generated from neural retinal tissue in aﬀected and
unaﬀected individuals. Alternative splicing in aﬀected individuals
results in a frame shift and introduction of a premature STOP
codon. Reproduced with permission from [27].
Recently, it has been shown that rdAc cats exhibit some
degree of phenotypic variation, with end-stage blindness
reached in individuals anywhere from three to seven years
[49]. Interestingly, it appears that the slow progression of
disease may be one of the factors leading to the cat’s excep-
tional ability to adapt to decreasing retinal function [49].
The condition thus evaded detection by both owners and
veterinarians in a highly popular cat breed, the Siamese,
which demonstrates a high frequency (∼33%) for the
rdAc disease allele [49]. Breeding practices have caused the
CEP290 mutation to spread to multiple cat breeds [49], and
to exhibit a worldwide distribution [49].
5. The Rod Cone DysplasiaCat Model (Rdy)
A second feline model of human retinal dystrophy, the Rdy
cat, was ﬁrst described in a single Abyssinian cat, from which
a pedigree was developed and extensively studied on a phe-
notypic level [50–53]. The disease is an early onset primary
photoreceptor disorder with an autosomal dominant (AD)
mode of inheritance in which aﬀected individuals exhibit
abnormal photoreceptor development at 22 days of age. The
disease leads rapidly to blindness usually within the ﬁrst few
months of life. Further characterization of the dystrophy
has demonstrated that the photoreceptors never develop
normally, and the disease has therefore been designated as
a rod-cone dysplasia with early onset degeneration of both
cones and rods.
The molecular genetic basis for Rdy was recently eluci-
dated [26]. A single-base deletion in the CRX gene intro-
duces a frameshift and a stop codon immediately down-
stream, truncating a region previously demonstrated as
critical for gene function [26, 54] (Figure 4). The CRX
gene product is critical in transcriptional activation of a
number of genes involved in photoreceptor development
and maintenance [55, 56]. In humans, mutations in CRX
are associated with human AD cone-rod dystrophy (CoRD),
and both AD and AR Leber’s congenital amaurosis (LCA)
[54, 57–59]. The Rdy cat is the ﬁrst large animal model for
CRX-linked spontaneous retinal disease. A large screening
of cat breeds has failed to detect any other domestic feline
breeds with the disease allele [26].
The Rdy model provides one of the very few large animal
models of an autosomal dominant retinal disease. These
disorders are challenging from a therapeutic standpoint.
Causality of the disease can arise from haploinsuﬃciency of
product, or in some circumstances from gain of function or
competition from a truncated or aberrant protein product
[60]. The presence of both mutant and wildtype RNA in Rdy
individuals,initiallysuggestivethatatruncatedCRXproduct
might be generated [26] has been supported by recent ﬁnd-
ings (K. Holland Deckman, unpublished). The truncated
peptide would retain the CRX motifs involved in nuclear
localization and DNA-binding, but lack the region critical
for transcriptional activation of photoreceptor speciﬁc genes
[61]. This truncated product could thus compete with the
wildtype CRX product and other transcription factors for
promoter binding regions of target genes, which is currently
under investigation.
6. Other Cat Models under Investigation
In the late 1960s, a new feline breed, the Bengal, which has
gained huge popularity, was developed through hybridiza-
tionofdomesticcatsandtheAsianleopardcat[62].Recently,
a novel, early onset autosomal recessive disorder was
described in this breed [63]. The disease is under investiga-
tion but appears to be an early onset primary photoreceptor
disorder, leading to blindness within the ﬁrst year of age.
Geneticmappingandfurthercharacterizationofthedisorder
are in progress. A second feline retinal disease model has
been described in the Persian cat breed [64]. The rod cone
dysplasia demonstrates an autosomal recessive mode of
inheritance [64]. Aﬀected individuals showed clinical signs
of disease 2-3 weeks after birth and clinical blindness at
16 weeks of age. Photoreceptors in aﬀected individuals
never reach full maturity. The molecular genetic defect for
both of these disorders has not as yet been elucidated. It
appears that the Bengal cat retinal disease should becomeJournal of Ophthalmology 5
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Figure 4: CRX protein structure in Felis catus. Wildtype feline CRX protein (a) compared to the putative truncated CRX protein (b). The
exon splice junctions are noted as “Y”. The start codon and stop codons are labeled as (∗) and (X), respectively. The protein domains are
highlighted as shaded boxes and deﬁned as the homeobox, the WSP domain, the transcriptional transactivation domains 1 and 2 (TTD1
and TTD2), and the OTX tail. Domains are drawn to scale. Reproduced with permission from [26].
an important animal model for the research community in
regards to the study of various treatment modalities. The
disease starts out from a mainly normal appearing retina but
due to the fast progression of the disorder, retinal atrophy
ensues comparatively early thus functioning as an eﬀective
model system for retinal research.
7. Therapeutic Intervention
The retinas of large animal models more closely approximate
that of humans, and are thus more easily amenable for
visualizationandimaging[65]ofthediseaseprocess,forsur-
gical intervention, and for clinical evaluation of therapeutic
eﬀects. Dogs and cats also oﬀer the potential of long-term
followup studies in conjunction with treatment trials.
The rod and cone photoreceptors (the latter; short and
middle wavelength sensitive cones) of both species are dis-
tributed in the retina in a mosaic pattern comparable to
that of the human retina. Neither cats nor dogs have a
macula. However, in cats, in the same region as the human
macula, there sre a cone-rich region called the area centralis
where the concentration of cones in comparison to that
of rods is higher than at any other location. Along with
the holangiotic conﬁguration of the retinal vasculature,
the cat retina becomes structurally similar to the human
counterpart.Further,catsinparticular,havehistoricallybeen
important models in neuroanatomy and neurophysiology,
especially with respect to visual function.
Successful therapeutic intervention is the ultimate goal
of research using animal models for human retinal disease
processes. In recent years, groundbreaking research has been
performed by independent groups in regards to gene therapy
usingdogswithspontaneoushereditaryretinaldisease.Proof
of principle that the technology works was achieved by
an in vivo study by Acland et al. [66], using AAV2/2 as
as a f ea n de ﬀective vector. The well-characterized rdAc
and Rdy feline models of spontaneous hereditary retinal
disease, now with known mutations, are excellent candidates
for gene therapy-based approaches, especially for the late
onset type of retinal degeneration (Jean Bennett, personal
communication, 2007). Gene therapy approaches targeting
the Rdy model, which has been recently elucidated on the
molecular genetic level, are currently under investigation.
Noveltherapeuticinterventionshaverecentlybeendevel-
oped to target aberrant RNA species that survive nonsense
mediated decay. Short interfering RNA (shRNA), short
double stranded RNA molecules, can be designed to degrade
speciﬁctargetmRNAs[67],whileribozymes,whicharesmall
catalytic RNAs, are designed to cleave complementary RNA
sequences [2]. RNA interference-mediated suppression and
replacement aims to remove both wildtype and aberrant
RNA copies of a targeted gene while replacing wildtype
expression with a copy of the gene.
Other methods of treatment include retinal transplan-
tation of viable cells or tissue. Experimentation in this
regard includes the replacement of dying visual cells with
healthy neuroblastic progenitor cells and retinal pigment
epithelial (RPE) cells as sheets of normal tissue [68]. It
has been demonstrated that retinal transplants in rats can
morphologically reconstruct a damaged retina and restore
retinal sensitivity [69]. Aﬀe c t e dc a t sw i t ht h eCEP290 defect
(rdAc) have been used in trials with transplantation of sheets
of allogeneic fetal retinal tissue [70]. Surgeries have been
successful as to graft survival in the retina, although cellular
connectivity has not been shown and ERG testing has not
demonstratedimprovementinretinalfunction.Sofarthecat
model in regards to transplantation of large sheets of normal
tissuehasshownacomparativelyhighriskforcomplications.
The tight structures of the cat eye presents diﬃculties to
manipulate the globe in the orbit in comparison to other
large animal models (such as dog, pig, and rabbits) and the
high frequency of hemorrhage from the deep venous plexus
region of the domestic cat renders this surgery diﬃcult even
for experienced surgeons [71].
Transplantation of stem and neural progenitor cells
appears to oﬀer considerable promise. Subretinal transplan-
tation of neural progenitor cells in rats has shown evidence
of cellular repopulation of damaged retinas and retardation
of ongoing retinal degeneration [72, 73]. Neural progenitor
cells can also be engineered to secrete speciﬁc growth factors
such as glial cell line-derived neurotrophic factor (GDNF).
When used for transplantation studies such cells contributed
to enhanced cellular survival, neuronal diﬀerentiation, and
improved host cognitive function following brain injury, in
comparison to transplantation of nontransduced neuronal
progenitor cells [74]. Recent studies, using rdAc animals6 Journal of Ophthalmology
have shown promising results when retinal progenitor cells
from transgenic ﬂuorescent red cats were transplanted to
cats aﬀected by the CEP290 mutation (rdAc) by subretinal
injections of progenitor cell suspensions. No adverse reac-
tions were observed in the transplanted cat eyes. There was
further development and migration of transplanted cells
in the outer and inner retina, and development of donor
progenitor cells speciﬁcally into M¨ uller-like cells observed by
immunohistochemistry [63]. Further studies are in progress.
Another modality under development using the feline
species is intraocular implantation of retinal prosthesis [75].
Either epiretinal or subretinal implantation can be utilized
in the degenerate retina. The electrodes in the prosthesis
may emit electrical currents and stimulate residual retinal
cells, such as second- and third- order neurons, for example,
bipolar and ganglion cells. Signals to the visual cortex are
transmitted to produce a visual sensation. It appears that
the cat eye, with the visual processes already thoroughly
investigated, would be an optimal animal model for further
development of research in regards to retinal prosthesis.
8. FutureDirections
Through discoveries of causative mutations and their detri-
mental eﬀects on retinal cell function, new insights into
retinal degenerative disease mechanisms have been gained.
It is now possible to aim therapies at correcting disease
mutations in the eye directly or indirectly. The cat species,
with disease entities that are comparable to those of humans,
and with large human-like eyes, is amenable to treatment
using similar surgical techniques and instrumentation as
those used for humans. We now have an eﬀective model
system that can be used for cell replacement therapy, retinal
transplantation using tissue from healthy retinas or retinal
progenitor cells, artiﬁcial retinal prosthesis, or combinations
of one or more of the above. There deﬁnitely is some hope of
further advancement in the ﬁeld of spontaneously occurring
hereditary retinal blinding disease using the cat as a valuable
large animal model.
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